BioXcel Therapeutics Inc
NASDAQ:BTAI
BioXcel Therapeutics Inc
Other Non-Cash Items
BioXcel Therapeutics Inc
Other Non-Cash Items Peer Comparison
Competitive Other Non-Cash Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
Other Non-Cash Items
$20.2m
|
CAGR 3-Years
1%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Non-Cash Items
$7.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
29%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Non-Cash Items
$8.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
35%
|
CAGR 10-Years
37%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Non-Cash Items
$1.8B
|
CAGR 3-Years
157%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Non-Cash Items
$585.3m
|
CAGR 3-Years
42%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Non-Cash Items
$1.2B
|
CAGR 3-Years
110%
|
CAGR 5-Years
21%
|
CAGR 10-Years
16%
|
See Also
What is BioXcel Therapeutics Inc's Other Non-Cash Items?
Other Non-Cash Items
20.2m
USD
Based on the financial report for Mar 31, 2024, BioXcel Therapeutics Inc's Other Non-Cash Items amounts to 20.2m USD.
What is BioXcel Therapeutics Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
47%
Over the last year, the Other Non-Cash Items growth was -6%. The average annual Other Non-Cash Items growth rates for BioXcel Therapeutics Inc have been 1% over the past three years , 47% over the past five years .